Skip to content
★ Sign in to follow
AL
Total declarations
7
Company
1
▲ Purchases (7 ops.)
€32k
▼ Sales (0 ops.)
—

Latest filing published 05 Dec 2008 for Perspective Therapeutics, Inc., €5,214.

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
7
Positive at T+90
0%
Median T+90
-10.0%

Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Albert Louis Smith: trading record in brief

This profile gathers the share dealings of Albert Louis Smith in Perspective Therapeutics, Inc. Between 12 November 2007 and 26 November 2008, the trades on record add up to 7 filings.

On the market, this insider has only ever bought: 7 purchases, €32k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2008, the count stands at 5 purchases and no sales.

A typical purchase (the median) is worth €3,648. Ninety days after publication, 7 purchases show a median change of -10.0%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.

On 5 December 2008 came the latest disclosure, an open-market purchase for €5,214 in Perspective Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 9 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Albert Louis Smith

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total

7 of 7 declarations